A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Lance Leopold, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
94 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Blacktown Hospital
Blacktown, New South Wales, Australia
- Chris Obrien Lifehouse
Camperdown, New South Wales, Australia
- the Crown Princess Mary Cancer Centre Westmead
Westmead, New South Wales, Australia
- Southern Medical Day Care Centre
Wollongong, New South Wales, Australia
- Mncci Port Macquarie Base Hospital
Port Macquarie, New South Wales (Australia), Australia
- Cairns Base Hospital
Cairns, Queensland, Australia
- Bcca-Cancer Centre of the Southern Interior
Kelowna, British Columbia, Canada
- Lions Gate Hospital
North Vancouver, British Columbia, Canada
- Cisss de la Monteregie-Centre
Greenfield Park, Quebec, Canada
- Csss de Laval- Hopital de la Cite de la Sante
Laval, Quebec, Canada
- Ciusss Ouest de L'Ile - St-Mary'S Hospital
Montreal, Quebec, Canada
- Ciusss Du Nord-de-L'Ile-de-Montreal Hopital Du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
- Chu de Quebec - Hotel-Dieu de Quebec
Québec, Quebec, Canada
- Ciusss de la Mauricie-Et-Du-Centre-Du-Quebec
Trois-Rivières, Quebec, Canada
- Zala Megyei Korhaz Pozvai Telephely
Pózva, Zalaegerszeg, Hungary
- Orszagos Koranyi Tbc Es Pulmonologiai Intezet
Budapest, Hungary
- Veszprem Megyei Tudogyogyintezet
Farkasgyepű, Hungary
- Bekes Megyei Pandy Kalman Korhaz
Gyula, Hungary
- Cru Hungary Kft.
Miskolc, Hungary
- Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet
Szolnok, Hungary
- St Vincents University Hospital
Dublin, Ireland
- Ha Emek Medical Center
Afula, Israel
- Soroka Medical Center
Beersheba, Israel
- Rambam Medical Center
Haifa, Israel
- Meir Medical Center
Kfar Saba, Israel
- Rabin Medical Center
Petah Tikva, Israel
- Chaim Sheba Medcal Center
Ramat Gan, Israel
- Centro Di Riferimento Oncologico
Aviano, Italy
- A.O.U. Policlinico Vittorio Emanuele - Presidio Gaspare Rodolico
Catania, Italy
- Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Ospedale San Gerardo - Asst Monza
Monza, Italy
- Medical Care Research S.A. de C.V.
Mérida, Yucatán, Mexico
- Oaxaca Site Management Organization S.C.
Oaxaca City, Mexico
- Faicic Clinical Research
Veracruz, Mexico
- Belgorod Regional Oncology Dispensary
Belgorod, Russia
- Udmurtia Republic Regional Clinical Oncology Dispensary
Izhevsk, Russia
- Republican Clinical Oncology Dispensary of Tatarstan Moh
Kazan', Russia
- Central Clinical Hospital With Polyclinic
Moscow, Russia
- Moscow Research Oncology Institute
Moscow, Russia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jan 2018
- Primary completion
- 13 Dec 2018
- Completion
- 16 Oct 2020
- Last update posted
- 24 Jan 2022
- Registered enrollment
- 233
- Registry id
- NCT03322566
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.